Gallagher Kathleen P. sold RNA
January 21, 2025 · Form 4 insider transaction
Gallagher Kathleen P. sold 1,295 shares of Atrium Therapeutics, Inc. at $28.59 per share, a transaction worth $37.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,295
Price
$28.59
Total value
$37.0K
InsiderGallagher Kathleen P.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 21, 2025
Filing dateJanuary 23, 2025
Shares owned after58,670
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.